Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 2021
DOI: 10.1016/b978-0-12-821567-8.00002-6
|View full text |Cite
|
Sign up to set email alerts
|

Investigational new drugs against glioblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 346 publications
0
1
0
Order By: Relevance
“…The most common subtype of GBM, known as primary GBM, arises de novo without any preceding low-grade precursor lesion. [27,28] Secondary GBM arises from the transformation of a lower-grade astrocytoma. [29] GBM is characterized by a wide range of genetic and epigenetic alterations that contribute to its aggressive behavior.…”
Section: Pathophysiology Of Glioblastomamentioning
confidence: 99%
“…The most common subtype of GBM, known as primary GBM, arises de novo without any preceding low-grade precursor lesion. [27,28] Secondary GBM arises from the transformation of a lower-grade astrocytoma. [29] GBM is characterized by a wide range of genetic and epigenetic alterations that contribute to its aggressive behavior.…”
Section: Pathophysiology Of Glioblastomamentioning
confidence: 99%